Reaction
Blood Bilirubin Decreased reporting signals
As of the last recalculation, Blood Bilirubin Decreased appears in 612 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is POLATUZUMAB VEDOTIN (PRR 42.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Polatuzumab Vedotin | 12 | 42.6 | 42.7 |
| Asfotase Alfa | 12 | 41.5 | 41.6 |
| Thiotepa | 9 | 32.5 | 32.5 |
| Ado-Trastuzumab Emtansine | 6 | 24.4 | 24.4 |
| Bendamustine Hcl | 9 | 20.0 | 20.0 |
| Fingolimod Hcl | 47 | 19.9 | 19.9 |
| Busulfan | 9 | 19.7 | 19.7 |
| Iron Sucrose | 5 | 18.0 | 18.0 |
| Azacitidine For | 9 | 17.1 | 17.1 |
| Voxelotor | 11 | 17.0 | 17.0 |
| Tenofovir Disoproxil Fumarate Tablets | 4 | 15.9 | 15.9 |
| Clozapine | 44 | 12.8 | 12.8 |
| Azacitidine | 10 | 11.6 | 11.6 |
| Bendamustine Hydrochloride | 4 | 11.4 | 11.4 |
| Avapritinib | 4 | 11.3 | 11.3 |
| Encorafenib | 3 | 10.4 | 10.4 |
| Trifluridine And Tipiracil | 3 | 9.6 | 9.6 |